Commonwealth Equity Services, LLC
- SEC CIK
- 0000312272
- Latest filing
- Jul 29, 2026
AVTX holding history
Avalo Therapeutics, Inc. in every 13F filed by Commonwealth Equity Services, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AVTX overviewAll 13F holders of AVTXFull Q2 2026 holdings
- Shares (Q3 2023)
- 0
- Sold out in Q3 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2023 | 0 | $0 | 0.0% | −10,762−100.0% | Sold out | Holders |
| Q2 2023 | 10,762 | $4.00K | <0.1% | +10,762 | New | Holders |
| Q3 2022 | 0 | $0 | 0.0% | −2,734−100.0% | Sold outConverted for a 1-for-12 split | Holders |
| Q2 2022 | 32,810 | $16.0K | <0.1% | −7,225−18.0% | Reduced | Holders |
| Q1 2022 | 40,035 | $29.0K | <0.1% | −11,965−23.0% | Reduced | Holders |
| Q4 2021 | 52,000 | $88.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 52,000 | $113.0K | <0.1% | +38,467+284.2% | Added | Holders |
| Q2 2021 | 13,533 | $44.0K | <0.1% | +13,533 | New | Holders |